Source FDA Certified Solid Silodosin for Urology and Research

Find and compare 30 listings for fda certified solid silodosin powder. Evaluate specifications including purity, packaging, and certifications to identify suitable suppliers for pharmaceutical intermediates and research applications.

Key considerations

Products List

Comprehensive Sourcing Guide

FDA Certified Solid Silodosin Sourcing Guide

Sourcing high-purity pharmaceutical intermediates and active ingredients requires a disciplined approach to verification, particularly when dealing with complex molecules like Silodosin. The core keyword "fda certified solid silodosin" signals a specific procurement intent focused on regulatory compliance and physical state. Buyers must understand that while the term "FDA certified" is frequently used in marketing, the U.S. Food and Drug Administration does not "certify" individual chemical suppliers or raw materials in the way it approves finished drug products. Instead, compliance is demonstrated through adherence to Current Good Manufacturing Practices (cGMP), rigorous documentation, and the ability to support the sponsor’s New Drug Application (NDA) or Abbreviated New Drug Application (ANDA). Therefore, the primary objective in this sourcing guide is to help buyers identify suppliers who can provide the necessary Quality Master File (QMF) or Drug Master File (DMF) support, ensuring that the solid Silodosin powder meets the stringent quality standards required for pharmaceutical formulation.

The physical characteristics of the product are a critical starting point for any procurement decision. Based on observed market data, Silodosin is typically available as a white crystalline powder, a form that facilitates accurate dosing and uniform mixing in tablet or capsule formulations. The molecular formula C17H14BrN3O2S and CAS Registry Number 160970-54-7 serve as the definitive identifiers for this compound, distinguishing it from other structural analogs or impurities. Buyers should verify that the supplier explicitly lists these identifiers on their certificates of analysis (COA) and technical data sheets. Furthermore, the observation that the product is solid and often packaged in standard export packages, such as aluminum foil bags within cardboard buckets or fiber drums, indicates a supply chain designed to protect the integrity of the powder from moisture and light, which are common degradation factors for sensitive pharmaceutical intermediates.

Product Scope and Observed Listing Signals

The current market landscape for Silodosin powder reveals a diverse range of supplier offerings, characterized by varying levels of customization and packaging specifications. Observed listings indicate that the product is available in both customized and non-customized forms, allowing buyers to select suppliers based on their specific formulation needs. For instance, some suppliers offer standard export packaging, while others provide specialized options like 1kg/bag and 25kg/fiber drum combinations, which are ideal for bulk industrial use. The presence of "Wholesales Price" attributes suggests that volume-based pricing models are prevalent, encouraging buyers to negotiate terms based on their anticipated consumption rates. It is essential for procurement teams to map these observed signals against their internal requirements, ensuring that the supplier’s packaging capabilities align with their storage infrastructure and handling protocols.

Another significant signal in the market is the emphasis on purity and quality grades. Many suppliers highlight a purity level of greater than 99%, which is a critical benchmark for pharmaceutical-grade active pharmaceutical ingredients (APIs). This high purity is often coupled with claims of "Medicine Grade" standards, indicating that the material is suitable for use in human therapeutics. Additionally, the observation that the product is suitable for various demographics, including adults, children, and the elderly, underscores its broad applicability in treating conditions such as benign prostatic hyperplasia (BPH). However, buyers must be cautious not to equate general suitability with specific regulatory approvals. The presence of attributes like "Refined Quality" and "White or Light Yellow Powder" provides visual and qualitative cues, but these should be validated through third-party testing and supplier audits rather than accepted at face value.

Technical Specifications to Verify

Verifying the technical specifications of Silodosin is paramount to ensuring product consistency and efficacy in final drug formulations. The molecular weight of the compound, often cited around 495.53 g/mol for related intermediates or analogs, serves as a fundamental check for identity. Buyers should request detailed analytical reports that confirm the molecular formula C17H14BrN3O2S and the CAS number 160970-54-7. It is also crucial to verify the physical state and appearance, ensuring that the powder matches the described white crystalline form. Discrepancies in color, such as a shift to light yellow, may indicate oxidation or impurities, necessitating further investigation into the supplier’s storage and handling practices. These technical parameters form the baseline for quality control and must be rigorously tested upon receipt.

Beyond identity, buyers must scrutinize the physical properties that affect processing, such as density and boiling point. While specific values like a density of 1.249 g/cm³ or a boiling point of 601.4±55.0 °C may be listed for related chemical intermediates, these figures are highly specific and may not apply directly to all Silodosin batches. Buyers should treat such numerical data as reference points rather than absolute guarantees. Instead, the focus should be on verifying the supplier’s ability to provide consistent particle size distribution, flowability, and solubility profiles. These processing characteristics are vital for manufacturing efficiency and product performance. Procurement teams should include these technical verification steps in their incoming quality inspection protocols to prevent production delays and ensure batch-to-batch consistency.

Compliance and Safety Documentation

Regulatory compliance is the cornerstone of sourcing pharmaceutical-grade Silodosin. While the term "FDA certified" is often used, buyers must verify that the supplier holds valid Good Manufacturing Practice (GMP) certifications. The observed data indicates that many suppliers claim GMP compliance, which is a non-negotiable requirement for producing materials intended for human use. Additionally, certifications such as ISO, USP, BP, and REACH are frequently mentioned, indicating adherence to international quality and safety standards. Buyers should request copies of these certificates and verify their validity with the issuing bodies. It is also important to ensure that the supplier’s quality management system is aligned with the regulatory requirements of the destination market, whether it is the United States, Europe, or Asia.

Safety documentation is equally critical, particularly regarding the handling and storage of the chemical. The observed attribute "Keep in Cool and Dry Place" highlights the need for proper environmental controls to maintain product stability. Buyers should ensure that the supplier provides a comprehensive Safety Data Sheet (SDS) that outlines hazards, first-aid measures, and safe handling procedures. Furthermore, the presence of certifications like HSE (Health, Safety, and Environment) suggests that the supplier prioritizes workplace safety and environmental responsibility. Procurement teams should review these documents to assess the supplier’s commitment to safety and to inform their own internal handling protocols. Failure to adhere to these safety guidelines can lead to product degradation, regulatory non-compliance, and potential health risks.

Cost Drivers and Commercial Terms

Understanding the cost drivers for Silodosin powder is essential for effective budgeting and negotiation. The observed price range of $0.4 to $892 USD reflects significant variability, likely driven by factors such as purity level, packaging size, and order quantity. The minimum order quantity (MOQ) ranges from 1 to 10,000 units, indicating that suppliers cater to both small-scale research and large-scale industrial production. Buyers should analyze their volume requirements to determine the most cost-effective purchasing strategy. For large-scale operations, negotiating bulk discounts and long-term supply agreements can significantly reduce per-unit costs. Conversely, smaller buyers may need to accept higher per-unit prices in exchange for lower MOQs and greater flexibility.

Commercial terms also play a crucial role in the total cost of ownership. Buyers should carefully review payment terms, shipping responsibilities, and return policies. The observed packaging options, such as 25kg drums or 1kg bags, impact logistics costs and storage requirements. Suppliers offering "Standard Export Package" may provide more predictable shipping costs, while customized packaging might incur additional fees. Additionally, the availability of samples, as noted in some listings, allows buyers to test product quality before committing to large orders. This can mitigate financial risk but may involve sample fees. Procurement teams should factor in these commercial variables to develop a comprehensive cost model that aligns with their financial and operational goals.

Supplier Qualification and Quality Control

Supplier qualification is a multi-step process that goes beyond reviewing certificates and price lists. Buyers should conduct thorough due diligence to assess the supplier’s manufacturing capabilities, quality control systems, and financial stability. This may involve on-site audits or third-party inspections to verify that the supplier’s facilities meet GMP standards. The observed attribute "Customization: Available" suggests that some suppliers offer tailored solutions, which can be beneficial for specific formulation needs. However, buyers must ensure that any customization does not compromise the integrity of the product or its regulatory status. Establishing a clear communication channel with the supplier is also vital for addressing technical queries and resolving issues promptly.

Quality control measures should be integrated into the procurement process from the outset. Buyers should define clear acceptance criteria for incoming materials, including purity, identity, and physical characteristics. Regular testing of received batches against these criteria is essential to maintain product quality. Additionally, buyers should establish a feedback loop with the supplier to address any non-conformities and drive continuous improvement. The observed emphasis on "Refined Quality" and "Medicine Grade" standards indicates that suppliers are aware of the high expectations in the pharmaceutical industry. By implementing robust quality control protocols, buyers can minimize the risk of receiving substandard materials and ensure the consistency of their final products.

Long-Term Procurement Checks

Long-term procurement success depends on continuous monitoring and relationship management. Buyers should regularly review supplier performance metrics, such as on-time delivery, product quality, and responsiveness to issues. The dynamic nature of the pharmaceutical industry means that regulatory requirements and market conditions can change rapidly. Buyers must stay informed about these changes and adapt their sourcing strategies accordingly. The observed availability of "Customized" products and various packaging options provides flexibility, but buyers should periodically reassess their needs to ensure they are leveraging the best available options. Building a strong partnership with reliable suppliers can lead to better pricing, priority service, and collaborative innovation.

Finally, buyers should maintain a diversified supplier base to mitigate supply chain risks. Relying on a single source for critical materials like Silodosin can expose the business to disruptions caused by production issues, regulatory actions, or geopolitical events. By qualifying multiple suppliers, buyers can ensure continuity of supply and maintain bargaining power. The observed global nature of the market, with suppliers from China and other regions, offers opportunities for diversification. However, buyers must ensure that all qualified suppliers meet the same rigorous quality and compliance standards. Regular audits and performance reviews are essential to maintaining the integrity of the supplier base and ensuring long-term procurement success.

FAQs

What is the purity level of the Silodosin powder?

The product purity is greater than 99 percent. This high-grade chemical reagent is available in a white crystalline powder form suitable for pharmaceutical intermediates and various drug applications.

Which certifications does the Silodosin powder hold?

The product holds GMP, Reach, BP, USP, ISO, and HSE certifications. These standards ensure the material meets strict quality requirements for medicine grade applications and regulatory compliance in international markets.

Can I request customized packaging for this chemical?

Customization is available for this product. Buyers can choose from standard export packages, aluminum foil bags, cardboard buckets, or drums depending on their specific logistical and storage requirements.

What is the minimum order quantity for this item?

The minimum order quantity ranges from one to ten thousand units. This flexibility allows buyers to source small samples or large industrial batches while maintaining the standard export packaging integrity.

How should the Silodosin powder be stored?

Store the product in a cool and dry place to maintain stability. The solid white powder is packed in drums or bags to ensure it remains safe for use as a pharmaceutical intermediate.

What is the molecular formula of this Silodosin powder?

The molecular formula is C17H14BrN3O2S for the specific variant listed. Another variant features the formula C25H32F3N3O4 with a molecular weight of 495.53 and a density of 1.249.

Where is this Silodosin powder manufactured?

The product originates from China. It is supplied as a refined synthesis material intermediate with a CAS registry number of 160970-54-7 or 10338-51-9 depending on the specific batch.